| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362714A 2-heterocycle(C-C bond)-4-oxobutanoate and preparation method thereof |
| 02/11/2009 | CN101362696A New preparation method of 3-aminomethyl-5-methyl butylacetic acic |
| 02/11/2009 | CN100460391C Chemical compounds. |
| 02/11/2009 | CN100460389C Pentazane derivative intermediate, preparation and use thereof |
| 02/10/2009 | US7488832 e.g. N-[amino(imino)methyl]-2-[2-(4-phenoxyphenyl)-5-phenyl-1H-pyrrol-1-yl]acetamide; beta -amyloid deposits and neurofibrillary tangles; cognition activator, neurodegenerative diseases; Alzheimer's disease, Down's syndrome |
| 02/10/2009 | US7488750 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 02/10/2009 | US7488747 Pyrrole and pyrazole DAAO inhibitors |
| 02/10/2009 | US7488725 To treat diabetes, especially type II diabetes including complications of diabetes; synergistic |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2208671C Substituted imides as tnf inhibitors |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | WO2009016221A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 02/05/2009 | WO2009016220A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives |
| 02/05/2009 | WO2009016048A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 02/05/2009 | WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | WO2008153958A3 Crystalline forms of (r)-1-{2-[4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 02/05/2009 | WO2008084383A3 Process for preparing vildagliptin |
| 02/05/2009 | US20090036628 Oxonium and sulfonium salts |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036421 Pyrrole Derivative or Salt Thereof |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | DE102008040340A1 Verfahren zum reinigenden Abtrennen von Acrylsäure-, Methacrylsäure-, N-Vinylpyrrolidon- oder p-Xylol-Kristallen aus ihrer Suspension in Mutterlauge A method for purifying removal of acrylic acid, methacrylic acid, N-vinylpyrrolidone or p-xylene crystals from their suspension in mother liquor |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694362A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 02/05/2009 | CA2692767A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives |
| 02/05/2009 | CA2692696A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/04/2009 | EP2020402A1 Dehydroxylated fluorinating agent |
| 02/04/2009 | EP2019821A1 Process for continuously preparing n- ethyl-2-pyrrolidone (nep) |
| 02/04/2009 | EP2019820A1 Therapeutic pyrrolidine compounds |
| 02/04/2009 | EP1565422B1 Vitamin d receptor modulators |
| 02/04/2009 | CN101360730A Fungicide N-cycloalkyl-benzyl-amide derivatives |
| 02/04/2009 | CN101360707A Thrombopoietin activity modulating compounds and methods |
| 02/04/2009 | CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
| 02/04/2009 | CN100457728C Tyrosine kinase inhibitors |
| 02/03/2009 | US7485731 Amidating a p-(benzyloxy)aniline derivative with (S)-N-(5-oxo-tetrahydro-furan-3-yl)-acetamide and cyclizing the product to form 1-(p-(benzyloxy)phenyl)-4-acetamido-2-pyrrolidone derivatives; N-(p-(benzyloxy)phenyl-3-acetamido-4-hydroxybutyramide derivatives |
| 02/03/2009 | US7485665 Medicinal composition |
| 02/03/2009 | US7485664 Inhibitors of TACE |
| 02/03/2009 | US7485427 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
| 01/29/2009 | WO2009013293A1 Substituted cyclohexanecarboxamides useful as bace inhibitors |
| 01/29/2009 | WO2009012998A1 Novel microbiocides |
| 01/29/2009 | WO2008148801A3 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 01/29/2009 | WO2008116339A3 Organic compounds |
| 01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 01/29/2009 | US20090030212 Intermediates (synthons) in the synthesis of pharmaceuticals such as oseltamivir and other products; treating the arizidine with the nucleophile in the presence of a biaryl phosphoric acid catalyst |
| 01/29/2009 | US20090029962 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 01/29/2009 | US20090029939 Pre-organized tricyclic integrase inhibitor compounds |
| 01/29/2009 | DE102007034620A1 Neue B1-Antagonisten New B1 antagonists |
| 01/28/2009 | EP2018545A2 Biradical polarizing agents for dynamic nuclear polarization |
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/28/2009 | EP1951666B1 Pyroglutamic acid esters with improved biodegradability |
| 01/28/2009 | EP1448522B1 Gabusectin derivatives, method for the production thereof and use of the same |
| 01/28/2009 | CN101353348A 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimine) pyrrolidine-1-yl] substituted quinoline carboxylic acid derivative and preparation thereof |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/27/2009 | US7482475 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 01/27/2009 | US7482474 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
| 01/27/2009 | US7482451 Emissive phosphorescent organometallic compounds that produce electroluminescence; for use in organic light emitting devices |
| 01/27/2009 | US7482374 Pyrrolidine-2-ones as Factor Xa inhibitors |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/25/2009 | WO2009078694A1 Formulations comprising an asphaltene-dispersing/-inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides |
| 01/25/2009 | CA2708368A1 Formulations comprising an asphaltene-dispersing/inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides |
| 01/22/2009 | WO2009011551A2 Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof |
| 01/22/2009 | WO2009010554A1 Process for the enantioselective preparation of pregabalin |
| 01/22/2009 | WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/22/2009 | WO2009009812A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/22/2009 | US20090023935 Chemical intermediates for the production of novel antibiotics 10-(3-cyclopropylaminomethyl-4-fluoropyrrolidinyl)pyridobenzoxazine carboxylic acid derivatives which are effective against drug resistant bacteria |
| 01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
| 01/22/2009 | US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/22/2009 | US20090023916 Tetrazine-based bio-orthogonal coupling reagents and methods |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023757 Process for preparing bicyclic compounds |
| 01/22/2009 | US20090023735 Sulphonamide Derivatives |
| 01/22/2009 | CA2693843A1 Process for the enantioselective preparation of pregabalin |
| 01/22/2009 | CA2693015A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/21/2009 | EP2017273A1 Process for the enantioselective preparation of pregabalin |
| 01/21/2009 | EP2016048A1 A crystalline form b4 of atorvastatin magnesium and a process thereof |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101351444A Novel pyrrole derivates with histone deacetylation enzyme inhibition activity |
| 01/21/2009 | CN101348454A N-alkyloxyacyl substituted aryl pyrrole derivatives, preparation and use thereof |
| 01/21/2009 | CN101348453A Method for purifying proline |
| 01/21/2009 | CN100453532C Substituted anthranilamides for controlling invertebrate pests |
| 01/20/2009 | US7479571 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479530 Comprising one or more macromonomer units selected from perfluoroalkylpolyether, fluorinated poly(meth)acrylate, poly(perfluoroalkyl) (meth)acrylate, poly(fluoroalkyl) (meth)acrylamide, and fluorinated polyolefin, and one or more charged units; intraocular lenses |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479362 UV decomposable molecules and a photopatternable monomolecular film formed therefrom |
| 01/20/2009 | CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2393518C Amycomycin, a process for its production and its use as a pharmaceutical |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |